Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesPayablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Current Assets (2022 - 2025)

CervoMed's Current Assets history spans 9 years, with the latest figure at $30.6 million for Q3 2025.

  • For Q3 2025, Current Assets fell 37.29% year-over-year to $30.6 million; the TTM value through Sep 2025 reached $30.6 million, down 37.29%, while the annual FY2024 figure was $43.1 million, 332.34% up from the prior year.
  • Current Assets for Q3 2025 was $30.6 million at CervoMed, down from $38.1 million in the prior quarter.
  • Across five years, Current Assets topped out at $48.8 million in Q3 2024 and bottomed at $4.2 million in Q4 2022.
  • The 4-year median for Current Assets is $29.9 million (2022), against an average of $27.7 million.
  • The largest annual shift saw Current Assets crashed 56.72% in 2024 before it soared 384.31% in 2025.
  • A 4-year view of Current Assets shows it stood at $4.2 million in 2022, then skyrocketed by 139.67% to $10.0 million in 2023, then surged by 332.34% to $43.1 million in 2024, then fell by 28.95% to $30.6 million in 2025.
  • Per Business Quant, the three most recent readings for CRVO's Current Assets are $30.6 million (Q3 2025), $38.1 million (Q2 2025), and $38.6 million (Q1 2025).